Spain

Medibiofarma is a Spanish biotechnology company founded in 2016 with the aim of discovering and developing new therapies in immuno-oncology. The company is focused in small molecules modulating targets with the potential of improving the clinical efficacy of approved Anti-PD1/PDL1 antibodies.

Presenter: Julio Castro, CSO, Medibiofarma